SMITH STAN purchased 2.6% of their position (33.33K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $50.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/5/2025ACC: 0001127602-25-016869
+66.67K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
66.67K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+33.33K
Price / share
$1.50
Trade value
$50K
% of position
2.6%
6/3/2025
1.27M→1.31M
Total
Net shares
+33.33K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/3/2025 | P · Purchase | +33.33K | $1.50 | $50K | 2.6% | 1.27M | 1.31M |
| Total | +33.33K | $50K | ||||||
Derivative Transactions1
Warrants
Indirect
Converts to
Common Stock
33.33K shares
Shares
+33.33K
Strike price
1.71
Held after
33.33K
Exercisable
—
6/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock33.33K shares | 6/3/2025 | P · Purchase | +33.33K | 1.71 | — | 33.33K |